Nutragen Pharma Private Limited, a active private limited company, was established on 10 June 2005 in Chennai, Tamil Nadu, India. Engaging in pharma contract r&d within the trade sector, it holds CIN: U24232TN2005PTC056577. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹5.45 Cr.
It upholds a compliant status. Its leadership includes Padmini Sankaran (Director), Sujayababu Jayasankar (Managing Director), Neelakantan Sujaya Babu (Director). Past directors included Padmini Sankaran, Sujayababu Jayasankar, Achamma Oomman. It holds ₹1.84 Cr open charges and ₹1.49 Cr settled loans. Its latest AGM occurred on 04 November 2024, with the balance sheet filed on 31 March 2024. It is based at Door 65-A, First Floor, 5Th Street Bismillah Nagar, Vettuvenkeni, Chennai, Tamil Nadu, 600115.
U24232TN2005PTC056577
056577
10 June 2005
₹6.00 Cr
₹5.45 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Nutragen Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Padmini Sankaran | Director | 16 Jan 2009 | Current |
| Sujayababu Jayasankar | Managing Director | 10 Jun 2005 | Current |
| Neelakantan Sujaya Babu | Director | 10 Jun 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 27 Mar 2009 | Past |
| Pramod Abcsdd | Director | 16 Jan 2009 | Past |
| Pramod Abcsdd | Director | 16 Jan 2009 | Past |
| Pramod Abcsdd | Managing Director | 16 Jan 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nutragen Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.33% increase. The company also saw a substantial fall in profitability, with a 76.09% decrease in profit. The company's net worth Soared by an impressive increase of 98.5%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Nutragen Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹18,400,000.00
₹14,850,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 2025 | Others | ₹1.40 Cr | Open |
| 30 Sep 2021 | The South Indian Bank Limited | ₹4.40 M | Open |
| 21 Dec 2006 | State Bank Of Travancore | ₹1.49 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Nutragen Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nutragen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nutragen Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 1.40 Cr registered on 15 Mar 2025 with Charge ID 101114236 was modified on 27 Aug 2025. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 1.40 Cr with Charge ID 101114236 was registered on 15 Mar 2025. was completed.
Progress on Nutragen Pharma Private Limited last Annual general meeting of members was held on 04 Nov 2024 as per latest MCA records. was documented.
The activity Nutragen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
A charge with The South Indian Bank Limited amounted to Rs. 0.44 Cr with Charge ID 100493891 was registered on 30 Sep 2021. was recorded as a recent event.
A charge registered on 21 Dec 2006 via Charge ID 10053854 with State Bank Of Travancore was fully satisfied on 01 Nov 2019. was recorded as a recent event.
The CIN of Nutragen Pharma Private Limited is U24232TN2005PTC056577.
Nutragen Pharma Private Limited is headquartered at Door 65-A, First Floor, 5Th Street Bismillah Nagar, Vettuvenkeni, Chennai, Tamil Nadu, 600115.
Nutragen Pharma Private Limited was incorporated on 10 June 2005.
The current directors of Nutragen Pharma Private Limited are
The primary industry of Nutragen Pharma Private Limited is Trade.
Nutragen Pharma Private Limited is unlisted.
The authorized capital of Nutragen Pharma Private Limited is ₹6.00 Cr, and the paid-up capital is ₹5.45 Cr.
The compliance status of Nutragen Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX